(Q33626102)

28 July 2017

title

Synuclein gamma predicts poor clinical outcome in colon cancer with normal levels of carcinoembryonic antigen (English)

1 reference

28 July 2017

1 reference

1 reference

Caiyun Liu

1

1 reference

28 July 2017

Bin Dong

2

1 reference

28 July 2017

Aiping Lu

3

1 reference

28 July 2017

Like Qu

4

1 reference

28 July 2017

Xiaofang Xing

5

1 reference

28 July 2017

Lin Meng

6

1 reference

28 July 2017

Jian Wu

7

1 reference

28 July 2017

Y Eric Shi

8

1 reference

28 July 2017

Chengchao Shou

9

1 reference

28 July 2017

language of work or name

English

0 references

publication date

7 July 2010

1 reference

28 July 2017

1 reference

28 July 2017

volume

10

1 reference

28 July 2017

page(s)

359

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2407-10-359

28 July 2017

exact match

0 references

cites work

Applications of novel monoclonal antibodies specific for synuclein-gamma in evaluating its levels in sera and cancer tissues from colorectal cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2912867

Neuronal protein synuclein gamma predicts poor clinical outcome in breast cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2912867

Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2912867

Synuclein-gamma targeting peptide inhibitor that enhances sensitivity of breast cancer cells to antimicrotubule drugs

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2912867

Involvement of RHO GTPases and ERK in synuclein-gamma enhanced cancer cell motility

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2912867

Inhibition of synuclein-gamma expression increases the sensitivity of breast cancer cells to paclitaxel treatment

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2912867

gamma-synuclein has a dynamic intracellular localization

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2912867

Abnormal activation of the synuclein-gamma gene in hepatocellular carcinomas by epigenetic alteration

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2912867

Synuclein gamma inhibits the mitotic checkpoint function and promotes chromosomal instability of breast cancer cells

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2912867

Molecular staging for survival prediction of colorectal cancer patients

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2912867

Overexpression of synuclein-gamma in pancreatic adenocarcinoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2912867

Breast cancer-specific gene 1 interacts with the mitotic checkpoint kinase BubR1

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2912867

Expression of alpha-, beta-, and gamma-synuclein in glial tumors and medulloblastomas

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2912867

Clinical utility of biochemical markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2912867

Gamma-synuclein promotes cancer cell survival and inhibits stress- and chemotherapy drug-induced apoptosis by modulating MAPK pathways

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2912867

Gamma synuclein: subcellular localization in neuronal and non-neuronal cells and effect on signal transduction

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2912867

Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2912867

Transcriptional suppression of synuclein gamma (SNCG) expression in human breast cancer cells by the growth inhibitory cytokine oncostatin M.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2912867

Synucleins are expressed in the majority of breast and ovarian carcinomas and in preneoplastic lesions of the ovary

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2912867

Identification, localization and characterization of the human gamma-synuclein gene

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2912867

Alpha-synuclein in Lewy bodies

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2912867

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2912867

Identification of a breast cancer-specific gene, BCSG1, by direct differential cDNA sequencing

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2912867

The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease

21 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1471-2407-10-359

Synucleins are expressed in the majority of breast and ovarian carcinomas and in preneoplastic lesions of the ovary

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1471-2407-10-359

Diagnostic potential in bladder cancer of a panel of tumor markers (calreticulin, gamma -synuclein, and catechol-o-methyltransferase) identified by proteomic analysis

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1471-2407-10-359

Stage-specific expression of breast cancer-specific gene gamma-synuclein

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2912867

2000 update of American Society of Clinical Oncology colorectal cancer surveillance guidelines

30 October 2018

1 reference

12 December 2020

Is follow-up of colorectal cancer patients worthwhile?

1 reference

12 December 2020

Stimulation of breast cancer invasion and metastasis by synuclein gamma

1 reference

12 December 2020

Clinicopathological variables and p53 overexpression as a combined prognosticator for hematogenic recurrence in colorectal cancer

1 reference

12 December 2020

Loss of epigenetic control of synuclein-gamma gene as a molecular indicator of metastasis in a wide range of human cancers

1 reference

12 December 2020

Expression of neuronal protein synuclein gamma gene as a novel marker for breast cancer prognosis

1 reference

12 December 2020

Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection

1 reference

12 December 2020

Multimarker phenotype predicts adverse survival in patients with lymph node-negative colorectal cancer

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2407-10-359

1 reference

Dimensions Publication ID

28 July 2017

0 references

1 reference

28 July 2017

1 reference